{
    "nctId": "NCT06367088",
    "briefTitle": "Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer",
    "officialTitle": "Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",
    "overallStatus": "RECRUITING",
    "conditions": "Triple-negative Breast Cancer, Cadonilimab",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 27,
    "primaryOutcomeMeasure": "Objective Response Rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Recurrent or metastatic TNBC patients;\n* TNBC defined by immunohistochemistry as ER\\<1%, PR\\<1%, Her2=0\\~1+, or 2+ while HER2 Fish test shows no amplification\uff1b\n* Previous received no or only first line chemotherapy treatment for recurrent or metastatic TNBC\uff1bWhen the time between cancer metastasis and the end of adjuvant chemotherapy exceeds 1 year, the systemic chemotherapy for metastasis treatment is recorded as first-line treatment; When less than 1year, the systemic chemotherapy for metastasis treatment is recorded as second-line treatment\uff1b\n* ages 18 to 75 years at the time of signing the informed consent form (ICF);\n* Eastern Cooperative Oncology Group (ECOG) performance status (PS) score of 0 or 1;\n* expected survival of \u22653 months; at least one measurable lesion per RECIST (version1.1);\n* acceptable renal and liver function;\n\nExclusion Criteria:\n\n* They had received ICIs (i.e., anti-PD-1 antibodies, anti-PD-L1 antibodies, and anti-CTLA-4 antibodies.)\uff1b\n* Patients with active central nervous system (CNS) metastatic lesions or meningeal metastases\uff1b\n* Patients with an active autoimmune disease that requires systemic treatment in the past two years\uff1b\n* A known history of primary immunodeficiency\uff1b\n* Pregnant or lactating women\uff1b\n* Previous or current abnormalities of any disease, treatment, laboratory tests may confuse the study results, affect the subject's participation in the study",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}